
RESEARCH GRADE PEPTIDE
Next-gen peptide for metabolic & body composition support
Retatrutide is a multi-agonist peptide that targets GLP-1, GIP, and glucagon receptors — designed to support appetite regulation, metabolic health, and body composition optimization.
Retatrutide is a novel tri-agonist peptide that activates GLP-1, GIP, and glucagon receptors. It works synergistically to support appetite control, improve insulin sensitivity, enhance energy expenditure, and promote healthy weight management and metabolic function.
By targeting three pathways (GLP-1, GIP, Glucagon), Retatrutide offers enhanced efficacy over single or dual agonists. This comprehensive approach helps regulate hunger, improve glucose metabolism, and increase fat burning.
*For research use only. Not for human consumption.
RECONSTITUTE WITH 2 ML BAC WATER = 5 MG/ML
TIP — Evening injections are ideal to support appetite control and consistent results.
| WEEK* | DOSE (MG) | UNITS (U-100 SYRINGE) | VOLUME (ML) | FREQUENCY | NOTES |
|---|---|---|---|---|---|
| Weeks 1–2 | 0.5 mg | 10 units | 0.10 mL | Every evening | Start low & assess tolerance |
| Weeks 3–4 | 1.0 mg | 20 units | 0.20 mL | Every evening | Increase as needed |
| Weeks 5–6 | 1.5 mg | 30 units | 0.30 mL | Every evening | Assess progress |
| Weeks 7+ | 2.0 mg | 40 units | 0.40 mL | Every evening | Maintenance dose |
*Adjust dose based on individual response and research goals.
At 0.5 mL (0.5 mg) per dose, 5 days per week:
LASTS APPROX. 4 WEEKS
2 mL ÷ 0.5 mL = 4 doses · 20 doses ÷ 5 days = 4 weeks
DISCLAIMER: This protocol is informational only, based on personal research and shared user experiences. It does not replace medical advice, diagnosis, or treatment. Please do not take this as medical advice.